AMPH vs MTD · P/E 12, rev $732.0M vs P/E 27, rev $3.87B
Amphastar P (AMPH) versus Mettler-Toledo International Inc (MTD) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported MTD revenue for 2024-12-31 was $3.87B. Net income was $863.1M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Not investment advice. Open the AMPH and MTD stock pages for the full models.
Not investment advice.